StockWatch
·
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Business UpdateMay 7, 2026, 04:08 PM

Myriad Genetics to Participate in Two Upcoming Healthcare Conferences

AI Summary

Myriad Genetics announced that its management will participate in two upcoming healthcare conferences. The company will hold 1-to-1 investor meetings at the BofA Securities 2026 Health Care Conference on May 13, 2026. Additionally, Myriad management will conduct a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, which will be webcast live.

Key Highlights

  • Myriad Genetics management to participate in the BofA Securities 2026 Health Care Conference on May 13, 2026.
  • Management will hold 1-to-1 investor meetings at the BofA Securities conference.
  • Myriad will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.
  • A fireside chat at the Goldman Sachs conference is scheduled for 8:40 a.m. ET.
  • The Goldman Sachs presentation will be available via live audio webcast on Myriad's investor website.